Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LENZ Therapeutics

盘前交易 05-08 05:55:44 EDT

16.43

+0.25

+1.55%

最高16.50	最低15.97	成交量18.97万
今开16.37	昨收16.18	日振幅3.28%
总市值4.20亿	流通市值1.59亿	总股本2,553万
成交额310.92万	换手率1.97%	流通股本965.03万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":16.43,"timestamp":1715112000000,"preClose":16.18,"halted":0,"volume":189749,"delay":0,"floatShares":9650255,"shares":25533533,"eps":-7.221351,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.25,"latestTime":"05-08 05:55:44 EDT","open":16.37,"high":16.5,"low":15.97,"amount":3109192.389933,"amplitude":0.032756,"askPrice":21.37,"askSize":100,"bidPrice":6.58,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-7.221351,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715175000000},"adr":0,"listingDate":1624593600000,"adjPreClose":16.43,"postHourTrading":{"tag":"盘后","latestPrice":16.43,"preClose":16.43,"latestTime":"18:02 EDT","volume":1362,"amount":22318.2552,"timestamp":1715119358520},"volumeRatio":0.8268794993811989},"requestUrl":"/m/hq/s/LENZ","defaultTab":"news","newsList":[{"id":"2433748919","title":"Needham：重申Heron Therapeutics(HRTX.US)评级，由买入调整至买入评级, 目标价5.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433748919","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433748919?lang=zh_cn&edition=full","pubTime":"2024-05-08 17:46","pubTimestamp":1715161571,"startTime":"0","endTime":"0","summary":"Needham：重申Heron Therapeutics(HRTX.US)评级，由买入调整至买入评级, 目标价5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405081746138ae8467c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405081746138ae8467c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433762111","title":"Lisata Therapeutics Inc   预计每股亏损72美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433762111","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433762111?lang=zh_cn&edition=full","pubTime":"2024-05-08 10:55","pubTimestamp":1715136929,"startTime":"0","endTime":"0","summary":"   * Lisata Therapeutics Inc    将于5月9日公布截至2024年3月31日的财报，预计该公司的季度收入将保持不变。*    * LSEG的分析师平均预计Lisata Therapeutics Inc每股亏损72美分。* 华尔街对 Lisata Therapeutics Inc 的 12 个月目标价中位数为 14.50 美元，高于其上一次收盘价 2.75 美元。5月8日 - 本摘要于北京时间 5 月 8 日 02:54 机器生成。除非另有说明，所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433761016","title":"Sangamo Therapeutics Inc    预计每股亏损 21 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433761016","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433761016?lang=zh_cn&edition=full","pubTime":"2024-05-08 10:25","pubTimestamp":1715135125,"startTime":"0","endTime":"0","summary":"   * Sangamo Therapeutics Inc    将于5月9日公布截至2024年3月31日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于加利福尼亚州里士满的公司的营收将从去年同期的1.5796亿美元降至665.5万美元，降幅为95.8%。* LSEG 分析师对 Sangamo Therapeutics Inc 的平均预期是每股亏损 21 美分。* 华尔街对 Sangamo Therapeutics Inc 的 12 个月目标价中位数为 2.50 美元，高于其 0.54 美元的最新收盘价。5月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433457769","title":"Relmada Therapeutics Inc   预计每股亏损85美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433457769","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433457769?lang=zh_cn&edition=full","pubTime":"2024-05-08 10:04","pubTimestamp":1715133889,"startTime":"0","endTime":"0","summary":"   * Relmada Therapeutics Inc    将于5月8日公布截至2024年3月31日的财报，预计该公司的季度收入将保持不变。*    * LSEG的分析师平均预计Relmada Therapeutics Inc每股亏损85美分。* 华尔街对 Relmada Therapeutics Inc 的 12 个月目标价中位数为 7.75 美元，高于其上一次收盘价 3.82 美元。5月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433454768","title":"Oncternal Therapeutics Inc    预计每股亏损 2.88 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433454768","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433454768?lang=zh_cn&edition=full","pubTime":"2024-05-08 09:06","pubTimestamp":1715130401,"startTime":"0","endTime":"0","summary":"   * Oncternal Therapeutics Inc    将于5月9日公布截至2024年3月31日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，3位分析师的平均预期显示，这家总部位于加利福尼亚州圣地亚哥的公司的营收将从去年同期的20.3万美元下降13.0%，至17.667万美元。* LSEG 的分析师平均预计 Oncternal Therapeutics Inc 每股亏损 2.88 美元。* 华尔街对 Oncternal Therapeutics Inc 的 12 个月目标价中位数为 28.00 美元，高于其最新收盘价 8.52 美元。5月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433875785","title":"Revance Therapeutics Inc    预计每股亏损 75 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433875785","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433875785?lang=zh_cn&edition=full","pubTime":"2024-05-08 08:07","pubTimestamp":1715126843,"startTime":"0","endTime":"0","summary":"   * Revance Therapeutics Inc    将于5月9日发布截至2024年3月31日的季度业绩报告，预计该公司的季度收入将有所增长。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于田纳西州纳什维尔的公司的营收有望从去年同期的4933万美元增长14.8%，达到5663.4万美元。* LSEG 分析师对 Revance Therapeutics Inc 的平均预期是每股亏损 75 美分。* 华尔街对 Revance Therapeutics Inc 的 12 个月目标价中位数为 12.00 美元，高于其上次收盘价 4.38 美元。5月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433675883","title":"Aclaris Therapeutics Inc 报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2433675883","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433675883?lang=zh_cn&edition=full","pubTime":"2024-05-08 05:02","pubTimestamp":1715115778,"startTime":"0","endTime":"0","summary":"   * Aclaris Therapeutics Inc   报告，截至1月底的季度调整后每股亏损24美分，高于去年同期的每股-40美分。八位分析师对该季度的平均预期是每股亏损 29 美分。华尔街预期为每股-37美分至-8美分。* 营收为 240 万美元，同比下降 5.1%；分析师预期为 137 万美元。* Aclaris Therapeutics Inc公布的本季度每股收益为亏损24美分。* 该公司当季亏损 1694 万美元。* Aclaris Therapeutics Inc的股价本季度上涨了5.6%，今年迄今为止上涨了24.8%。* 华尔街对 Aclaris Therapeutics Inc 的 12 个月目标价中位数为 2.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433734031","title":"Vivos Therapeutics, Inc.盘中异动 临近收盘急速拉升5.04%报2.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433734031","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433734031?lang=zh_cn&edition=full","pubTime":"2024-05-08 03:57","pubTimestamp":1715111848,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日03时57分，Vivos Therapeutics, Inc.股票出现异动，股价大幅拉升5.04%。Vivos Therapeutics, Inc.股票所在的医疗器械行业中，整体涨幅为1.02%。其相关个股中，Nuwellis, Inc.、Bioventus Inc.、Xylo Technologies Ltd涨幅较大，Nuwellis, Inc.、Helius Medical Technologies, Inc.、Acutus Medical, Inc.较为活跃，换手率分别为869.45%、164.04%、13.10%，振幅较大的相关个股有Pavmed Inc C/Wts 30/04/2025 Class Z、Nuwellis, Inc.、Acutus Medical, Inc.，振幅分别为73.65%、70.18%、42.06%。Vivos Therapeutics, Inc.公司简介：Vivos Therapeutics Inc 是一家医疗技术公司。该公司通过包括定制的口腔矫治器和名为 Vivos 系统在内的方案来治疗轻度至中度 OSA。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508035728861eb883&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508035728861eb883&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433473492","title":"Karyopharm Therapeutics Inc.盘中异动 股价大跌5.22%报1.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433473492","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433473492?lang=zh_cn&edition=full","pubTime":"2024-05-08 03:53","pubTimestamp":1715111592,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日03时53分，Karyopharm Therapeutics Inc.股票出现波动，股价大幅下挫5.22%。截至发稿，该股报1.09美元/股，成交量84.439万股，换手率0.73%，振幅9.56%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.42%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508035312861eb881&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508035312861eb881&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433736959","title":"Galera Therapeutics, Inc.盘中异动 下午盘股价大涨5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433736959","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433736959?lang=zh_cn&edition=full","pubTime":"2024-05-08 02:27","pubTimestamp":1715106479,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日02时27分，Galera Therapeutics, Inc.股票出现异动，股价快速上涨5.72%。Galera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Galera Therapeutics, Inc.公司简介：Galera Therapeutics Inc 是一家生物制药公司，致力于开发和商业化新型专有疗法产品线，这些疗法有可能改变癌症的放射治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405080228007a5889ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405080228007a5889ab&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433873568","title":"Revance Therapeutics, Inc.盘中异动 大幅上涨5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433873568","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433873568?lang=zh_cn&edition=full","pubTime":"2024-05-08 02:07","pubTimestamp":1715105253,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日02时07分，Revance Therapeutics, Inc.股票出现波动，股价快速上涨5.61%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，Revelation Biosciences Inc C/Wts 10/01/2027 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Carmell Corp C/Wts 12/07/2028 涨幅较大，Clearmind Medicine Inc.、Allarity Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1460.73%、263.66%、193.57%，振幅较大的相关个股有Revelation Biosciences Inc C/Wts 10/01/2027 、Psyence Biomedical Ltd C/Wts 25/01/2029、Avenue Therapeutics, Inc.，振幅分别为96.50%、56.63%、42.73%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508020734861eb867&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508020734861eb867&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433735802","title":"Needham：重申Esperion Therapeutics(ESPR.US)评级，由买入调整至买入评级, 目标价8.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433735802","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433735802?lang=zh_cn&edition=full","pubTime":"2024-05-08 02:05","pubTimestamp":1715105114,"startTime":"0","endTime":"0","summary":"Needham：重申Esperion Therapeutics(ESPR.US)评级，由买入调整至买入评级, 目标价8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050802051687dd40b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050802051687dd40b9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433359587","title":"Oncternal Therapeutics, Inc.盘中异动 急速下挫8.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433359587","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433359587?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:55","pubTimestamp":1715104550,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日01时55分，Oncternal Therapeutics, Inc.股票出现波动，股价急速跳水8.11%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508015550861eb862&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508015550861eb862&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433119735","title":"Aileron Therapeutics, Inc.盘中异动 股价大跌5.95%报3.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433119735","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433119735?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:50","pubTimestamp":1715104213,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日01时50分，Aileron Therapeutics, Inc.股票出现波动，股价大幅下跌5.95%。Aileron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Revelation Biosciences Inc C/Wts 10/01/2027 、Oragenics Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Clearmind Medicine Inc.、Allarity Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1458.02%、254.90%、193.11%，振幅较大的相关个股有Revelation Biosciences Inc C/Wts 10/01/2027 、Psyence Biomedical Ltd C/Wts 25/01/2029、Avenue Therapeutics, Inc.，振幅分别为96.50%、56.63%、42.73%。Aileron Therapeutics, Inc.公司简介：Aileron Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508015013861eb860&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508015013861eb860&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433733217","title":"花旗：维持Pliant Therapeutics(PLRX.US)评级，由买入调整至买入评级, 目标价由45.00美元调整至44.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433733217","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433733217?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:45","pubTimestamp":1715103938,"startTime":"0","endTime":"0","summary":"花旗：维持Pliant Therapeutics(PLRX.US)评级，由买入调整至买入评级, 目标价由45.00美元调整至44.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801454187dd3672&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801454187dd3672&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433853733","title":"花旗：维持Axsome Therapeutics(AXSM.US)评级，由买入调整至买入评级, 目标价由127.00美元调整至125.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433853733","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433853733?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:24","pubTimestamp":1715102694,"startTime":"0","endTime":"0","summary":"花旗：维持Axsome Therapeutics(AXSM.US)评级，由买入调整至买入评级, 目标价由127.00美元调整至125.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801245687dd2aed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801245687dd2aed&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433738052","title":"Sangamo Therapeutics, Inc.盘中异动 下午盘大幅上涨5.11%报0.553美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433738052","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433738052?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:22","pubTimestamp":1715102573,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日01时22分，Sangamo Therapeutics, Inc.股票出现波动，股价快速上涨5.11%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801225379264f8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801225379264f8a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433738771","title":"Vyne Therapeutics Inc.盘中异动 下午盘股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433738771","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433738771?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:19","pubTimestamp":1715102353,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日01时19分，Vyne Therapeutics Inc.股票出现波动，股价快速上涨5.17%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.03%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。该信息摘要如下：HC Wainwright & Co.：重申VYNE Therapeutics评级，由买入调整至买入评级, 目标价5.75美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801191479264f85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801191479264f85&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433898738","title":"Aptevo Therapeutics Inc    预计每股亏损 12.84 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433898738","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433898738?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:06","pubTimestamp":1715101567,"startTime":"0","endTime":"0","summary":"   * Aptevo Therapeutics Inc    将于5月9日公布截至2024年3月31日的财报() 预计该公司的季度营收将保持不变。*    * LSEG 的分析师平均预计 Aptevo Therapeutics Inc 每股亏损 12.84 美元。* 华尔街对 Aptevo Therapeutics Inc 的 12 个月目标价中位数为 15.25 美元，高于其最新收盘价 1.11 美元。5月7日 - 本摘要于北京时间 5 月 7 日 17:06 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433352738","title":"Tenax Therapeutics, Inc.盘中异动 股价大跌5.37%报3.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433352738","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433352738?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:02","pubTimestamp":1715101379,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日01时02分，Tenax Therapeutics, Inc.股票出现波动，股价大幅跳水5.37%。Tenax Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.14%。Tenax Therapeutics, Inc.公司简介：Tenax Therapeutics Inc是一家专业制药公司，致力于识别、开发和商业化，解决那些盖度未满足医疗需求的心血管疾病和肺部疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801030087e862c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801030087e862c7&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://lenz-tx.com","stockEarnings":[{"period":"1week","weight":0.0353},{"period":"1month","weight":-0.1918},{"period":"3month","weight":-0.1962},{"period":"6month","weight":0.0074},{"period":"1year","weight":-0.2711},{"period":"ytd","weight":-0.1041}],"compareEarnings":[{"period":"1week","weight":0.0302},{"period":"1month","weight":-0.0025},{"period":"3month","weight":0.0382},{"period":"6month","weight":0.192},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.088}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"LENZ Therapeutics, Inc.于2017年6月1日加拿大安大略省注册成立，并于2019年10月在特拉华州重新注册。他们是一家临床阶段的下一代基因编辑公司，利用高效靶向基因整合开发新型疗法有可能治愈范围广泛的严重和危及生命的疾病。他们正在开创一种精确的基因编辑方法，以实现医学上最难以实现的目标之一：精确“找到并替换”基因组中的任何基因。他们的下一代基因编辑平台使他们能够精确地纠正突变，用正常基因替换整个致病基因，或将新基因插入预定的安全位置。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.187611},{"month":2,"riseRate":0.666667,"avgChangeRate":0.15153},{"month":3,"riseRate":0,"avgChangeRate":-0.19103},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.06634},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.163285},{"month":6,"riseRate":0.5,"avgChangeRate":0.042853},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.062127},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.052314},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.028796},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.037137},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.124883},{"month":12,"riseRate":0.666667,"avgChangeRate":0.157581}],"exchange":"NASDAQ","name":"Therapeutics","nameEN":"Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Therapeutics(LENZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Therapeutics,LENZ,Therapeutics股票,Therapeutics股票老虎,Therapeutics股票老虎国际,Therapeutics行情,Therapeutics股票行情,Therapeutics股价,Therapeutics股市,Therapeutics股票价格,Therapeutics股票交易,Therapeutics股票购买,Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Therapeutics(LENZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}